Episurf Medical AB (publ)
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more
Episurf Medical AB (publ) (EPIS-B) - Total Assets
Latest total assets as of December 2025: Skr59.80 Million SEK
Based on the latest financial reports, Episurf Medical AB (publ) (EPIS-B) holds total assets worth Skr59.80 Million SEK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Episurf Medical AB (publ) - Total Assets Trend (2009–2025)
This chart illustrates how Episurf Medical AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Episurf Medical AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2025)
Episurf Medical AB (publ)'s total assets of Skr59.80 Million consist of 29.6% current assets and 70.4% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 11.9% |
| Accounts Receivable | Skr5.50 Million | 9.2% |
| Inventory | Skr3.00 Million | 5.0% |
| Property, Plant & Equipment | Skr5.10 Million | 8.5% |
| Intangible Assets | Skr37.10 Million | 62.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2009–2025)
This chart illustrates how Episurf Medical AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Episurf Medical AB (publ)'s current assets represent 29.6% of total assets in 2025, a decrease from 40.3% in 2009.
- Cash Position: Cash and equivalents constituted 11.9% of total assets in 2025, down from 24.5% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 15.0% in 2009.
- Asset Diversification: The largest asset category is intangible assets at 62.0% of total assets.
Episurf Medical AB (publ) Competitors by Total Assets
Key competitors of Episurf Medical AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Episurf Medical AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Episurf Medical AB (publ) generates 0.23x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Episurf Medical AB (publ) is currently not profitable relative to its asset base.
Episurf Medical AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.70 | 4.29 | 10.95 |
| Quick Ratio | 1.41 | 4.06 | 10.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr7.30 Million | Skr 45.80 Million | Skr 130.30 Million |
Episurf Medical AB (publ) - Advanced Valuation Insights
This section examines the relationship between Episurf Medical AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.36 |
| Latest Market Cap to Assets Ratio | 0.09 |
| Asset Growth Rate (YoY) | -38.9% |
| Total Assets | Skr59.80 Million |
| Market Capitalization | $5.40 Million USD |
Valuation Analysis
Below Book Valuation: The market values Episurf Medical AB (publ)'s assets below their book value (0.09 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Episurf Medical AB (publ)'s assets decreased by 38.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Episurf Medical AB (publ) (2009–2025)
The table below shows the annual total assets of Episurf Medical AB (publ) from 2009 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr59.80 Million | -38.85% |
| 2024-12-31 | Skr97.80 Million | -6.23% |
| 2023-12-31 | Skr104.30 Million | -47.11% |
| 2022-12-31 | Skr197.20 Million | -27.12% |
| 2021-12-31 | Skr270.60 Million | +45.95% |
| 2020-12-31 | Skr185.40 Million | +221.88% |
| 2019-12-31 | Skr57.60 Million | +5.11% |
| 2018-12-31 | Skr54.80 Million | -41.26% |
| 2017-12-31 | Skr93.29 Million | +54.69% |
| 2016-12-31 | Skr60.30 Million | -48.98% |
| 2015-12-31 | Skr118.20 Million | +173.37% |
| 2014-12-31 | Skr43.24 Million | -43.42% |
| 2013-12-31 | Skr76.42 Million | +173.80% |
| 2012-12-31 | Skr27.91 Million | -44.78% |
| 2011-12-31 | Skr50.55 Million | +348.38% |
| 2010-12-31 | Skr11.27 Million | +835.53% |
| 2009-12-31 | Skr1.20 Million | -- |